Vident Advisory LLC lifted its position in The Allstate Corporation (NYSE:ALL - Free Report) by 20.9% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 10,439 shares of the insurance provider's stock after buying an additional 1,804 shares during the period. Vident Advisory LLC's holdings in Allstate were worth $2,162,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds have also recently modified their holdings of ALL. Brighton Jones LLC boosted its stake in shares of Allstate by 60.2% in the 4th quarter. Brighton Jones LLC now owns 6,500 shares of the insurance provider's stock worth $1,253,000 after buying an additional 2,443 shares during the last quarter. Revolve Wealth Partners LLC purchased a new position in shares of Allstate in the fourth quarter valued at about $231,000. AXA S.A. lifted its position in shares of Allstate by 85.4% in the fourth quarter. AXA S.A. now owns 33,470 shares of the insurance provider's stock valued at $6,453,000 after acquiring an additional 15,415 shares in the last quarter. Aptus Capital Advisors LLC lifted its position in shares of Allstate by 48.5% in the fourth quarter. Aptus Capital Advisors LLC now owns 5,197 shares of the insurance provider's stock valued at $1,004,000 after acquiring an additional 1,697 shares in the last quarter. Finally, Benjamin Edwards Inc. lifted its position in shares of Allstate by 12.2% in the fourth quarter. Benjamin Edwards Inc. now owns 38,540 shares of the insurance provider's stock valued at $7,435,000 after acquiring an additional 4,178 shares in the last quarter. 76.47% of the stock is currently owned by hedge funds and other institutional investors.
Allstate Trading Down 3.3%
Shares of NYSE ALL traded down $6.94 during trading hours on Friday, reaching $201.39. The stock had a trading volume of 1,404,997 shares, compared to its average volume of 1,111,447. The Allstate Corporation has a 52-week low of $176.00 and a 52-week high of $214.76. The business's fifty day moving average price is $200.72 and its two-hundred day moving average price is $200.03. The company has a current ratio of 0.43, a quick ratio of 0.43 and a debt-to-equity ratio of 0.37. The firm has a market cap of $53.07 billion, a price-to-earnings ratio of 9.47, a P/E/G ratio of 0.81 and a beta of 0.37.
Allstate (NYSE:ALL - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $5.94 EPS for the quarter, beating the consensus estimate of $3.20 by $2.74. Allstate had a return on equity of 28.74% and a net margin of 8.79%.The firm had revenue of $15.05 billion during the quarter, compared to analyst estimates of $16.59 billion. During the same quarter in the prior year, the business posted $1.61 EPS. The business's revenue for the quarter was up 5.8% compared to the same quarter last year. Analysts expect that The Allstate Corporation will post 18.74 EPS for the current fiscal year.
Allstate Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 1st. Stockholders of record on Friday, August 29th will be issued a dividend of $1.00 per share. This represents a $4.00 annualized dividend and a dividend yield of 2.0%. The ex-dividend date is Friday, August 29th. Allstate's dividend payout ratio is currently 18.81%.
Analyst Ratings Changes
ALL has been the topic of several research reports. UBS Group lifted their target price on Allstate from $230.00 to $235.00 and gave the stock a "buy" rating in a report on Wednesday, July 9th. Wells Fargo & Company set a $202.00 target price on Allstate and gave the stock an "equal weight" rating in a report on Tuesday, August 5th. Wall Street Zen raised Allstate from a "hold" rating to a "buy" rating in a report on Tuesday, August 5th. Keefe, Bruyette & Woods lifted their target price on Allstate from $237.00 to $246.00 and gave the stock an "outperform" rating in a report on Wednesday, August 6th. Finally, Raymond James Financial reissued a "strong-buy" rating and set a $260.00 price objective (up from $250.00) on shares of Allstate in a research note on Monday, August 4th. One research analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $231.21.
Read Our Latest Analysis on ALL
Allstate Profile
(
Free Report)
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
See Also

Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.